| Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature PG Arnison, MJ Bibb, G Bierbaum, AA Bowers, TS Bugni, G Bulaj, ... Natural product reports 30 (1), 108-160, 2013 | 2017 | 2013 |
| An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II HE Hasper, NE Kramer, JL Smith, JD Hillman, C Zachariah, OP Kuipers, ... Science 313 (5793), 1636-1637, 2006 | 602 | 2006 |
| Occidiofungin, a Unique Antifungal Glycopeptide Produced by a Strain of Burkholderia contaminans SE Lu, J Novak, FW Austin, G Gu, D Ellis, M Kirk, S Wilson-Stanford, ... Biochemistry 48 (35), 8312-8321, 2009 | 149 | 2009 |
| Therapeutic potential of type A (I) lantibiotics, a group of cationic peptide antibiotics L Smith, JD Hillman Current opinion in microbiology 11 (5), 401-408, 2008 | 102 | 2008 |
| Oxidation of lanthionines renders the lantibiotic nisin inactive S Wilson-Stanford, A Kalli, K Håkansson, J Kastrantas, RS Orugunty, ... Applied and Environmental Microbiology 75 (5), 1381-1387, 2009 | 88 | 2009 |
| Elucidation of the antimicrobial mechanism of mutacin 1140 L Smith, H Hasper, E Breukink, J Novak, J Čerkasov, JD Hillman, ... Biochemistry 47 (10), 3308-3314, 2008 | 87 | 2008 |
| Two flavoenzymes catalyze the post-translational generation of 5-chlorotryptophan and 2-aminovinyl-cysteine during NAI-107 biosynthesis MA Ortega, DP Cogan, S Mukherjee, N Garg, B Li, GN Thibodeaux, ... ACS chemical biology 12 (2), 548-557, 2017 | 83 | 2017 |
| Biosynthesis of an antifungal oligopeptide in Burkholderia contaminans strain MS14 G Gu, L Smith, N Wang, H Wang, SE Lu Biochemical and biophysical research communications 380 (2), 328-332, 2009 | 74 | 2009 |
| Genetic and biochemical map for the biosynthesis of occidiofungin, an antifungal produced by Burkholderia contaminans strain MS14 G Gu, L Smith, A Liu, SE Lu Applied and Environmental Microbiology 77 (17), 6189-6198, 2011 | 73 | 2011 |
| Structure and dynamics of the lantibiotic mutacin 1140 L Smith, C Zachariah, R Thirumoorthy, J Rocca, J Novák, JD Hillman, ... Biochemistry 42 (35), 10372-10384, 2003 | 68 | 2003 |
| Covalent structure of mutacin 1140 and a novel method for the rapid identification of lantibiotics L Smith, J Novák, J Rocca, S McClung, JD Hillman, AS Edison European journal of biochemistry 267 (23), 6810-6816, 2000 | 65 | 2000 |
| Evolution of lantibiotic salivaricins: new weapons to fight infectious diseases A Barbour, P Wescombe, L Smith Trends in microbiology 28 (7), 578-593, 2020 | 56 | 2020 |
| Site-directed mutations in the lanthipeptide mutacin 1140 S Chen, S Wilson-Stanford, W Cromwell, JD Hillman, A Guerrero, ... Applied and environmental microbiology 79 (13), 4015-4023, 2013 | 56 | 2013 |
| Comparative genome‐wide analysis reveals that Burkholderia contaminans MS14 possesses multiple antimicrobial biosynthesis genes but not major genetic loci … P Deng, X Wang, SM Baird, KC Showmaker, L Smith, DG Peterson, S Lu Microbiologyopen 5 (3), 353-369, 2016 | 54 | 2016 |
| Occidiofungin's Chemical Stability and In Vitro Potency against Candida Species D Ellis, J Gosai, C Emrick, R Heintz, L Romans, D Gordon, SE Lu, F Austin, ... Antimicrobial agents and chemotherapy 56 (2), 765-769, 2012 | 54 | 2012 |
| The antifungal occidiofungin triggers an apoptotic mechanism of cell death in yeast D Emrick, A Ravichandran, J Gosai, S Lu, DM Gordon, L Smith Journal of natural products 76 (5), 829-838, 2013 | 53 | 2013 |
| IA3, an Aspartic Proteinase Inhibitor from Saccharomyces cerevisiae, Is Intrinsically Unstructured in Solution TB Green, O Ganesh, K Perry, L Smith, LH Phylip, TM Logan, SJ Hagen, ... Biochemistry 43 (14), 4071-4081, 2004 | 51 | 2004 |
| AmbR1 is a key transcriptional regulator for production of antifungal activity of Burkholderia contaminans strain MS14 G Gu, N Wang, N Chaney, L Smith, SE Lu FEMS microbiology letters 297 (1), 54-60, 2009 | 42 | 2009 |
| Occidiofungin is an important component responsible for the antifungal activity of Burkholderia pyrrocinia strain Lyc2 XQ Wang, AX Liu, A Guerrero, J Liu, XQ Yu, P Deng, L Ma, SM Baird, ... Journal of applied microbiology 120 (3), 607-618, 2016 | 41 | 2016 |
| A Novel Actin Binding Drug with In Vivo Efficacy A Ravichandran, M Geng, KG Hull, J Li, D Romo, SE Lu, A Albee, C Nutter, ... Antimicrobial agents and chemotherapy 63 (1), 10.1128/aac. 01585-18, 2019 | 34 | 2019 |
